Format

Send to

Choose Destination
Hum Immunol. 2016 Dec;77(12):1280-1283. doi: 10.1016/j.humimm.2016.09.007. Epub 2016 Sep 21.

IL28B gene variants and glucose metabolism in Type 2 Diabetes.

Author information

1
Department of Internal Medicine I, Division of Endocrinology, Diabetes and Metabolism, University Frankfurt, Frankfurt am Main, Germany. Electronic address: yasmin_moran@gmx.de.
2
Department of Internal Medicine I, Division of Endocrinology, Diabetes and Metabolism, University Frankfurt, Frankfurt am Main, Germany.
3
Occupational Health Service, University Frankfurt, Frankfurt am Main, Germany.

Abstract

Type 2 Diabetes (T2D) develops, when β-cell insulin response fails to compensate for insulin resistance. Recent studies reported associations between the IL28B polymorphisms (rs12979860 and rs8099917) and T2D development in Hepatitis C virus (HCV) patients. To identify possible association with T2D independent from virus infection, we investigated both IL28B polymorphisms in T2D patients and healthy controls (HC). No association was found comparing the genotype and allele frequencies of both IL28B polymorphisms between T2D patients and HC. However, higher glucose levels were found in T2D patients carrying the IL28B CT/TT rs12979860 and GT/GG rs8099917 HCV risk genotypes compared to those with the protective CC and TT genotype (p=0.06 and p=0.02, respectively). Moreover, T2D patients with CT/TT rs12979860 HCV risk genotypes possessed significantly higher HbA1c levels than CC carriers (p=0.04). In conclusion, the IL28B HCV risk genotypes may influence glucose homeostasis in T2D patients without HCV.

KEYWORDS:

Glucose; HOMA-IR; IL28B; T2D

PMID:
27664841
DOI:
10.1016/j.humimm.2016.09.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center